Lung Cancer
BNT327-06: A Phase II/III, multisite, randomized master protocol for a global trial of BNT327 in combination with chemotherapy and other investigational agents in first-line non-small cell lung cancer
- Details
ClinicalTrials.gov ID:
NCT06712316
Diagnosis Type:
NA
USOR Number:
- Address
,
P: